At IMS, we help customers determine how to best allocate resources across their portfolios to maximize performance at every stage of the product lifecycle.  IMS offers an array of services and solutions to give clients fast, accurate information about the global pharmaceutical market. Available in hard copy, CD-ROM or on the web, our global portfolio optimization tools cover:

• Drug Intelligence, providing global product R&D and lifecyle information. Specific services include IMS Knowledge Link^TM, IMS LifeCycle^TM, R&D Focus, Patent Focus, New Product Focus^TM, Drug News, Conferences & Events Database, IMS Drug Monographs^TM  and IMS Retail Drug Monitor.

• Company and Market Studies, offering qualitative and quantitative data on global markets and industry players.  Services include IMS World Review, IMS World Review Analyst, IMS World Review Monthly, IMS World Review Medical, IMS Company Profiles, and IMS Sales Tracker.

• Chemical & Generic Information, covering the R&D pharmaceutical pipeline.  Services include IMS Chemical Kilochem Profile, IMS Chemical Actives Monitor, IMS World Review Actives & Brands, ChemIndex, IMS Chemical Country Profiles, IMS Generic Planner, IMS World Review Generic and IMS Generic Market Analyzer.

• Sales Analysis, timely, global, in-depth information on prescription drug sales. Services include IMS MIDAS^TM, IMS MIDAS Dispensing Insights^TM, IMS MIDAS Customized Insights^TM  and IMS MIDAS Monthly^TM.

• Hospital and Medical Information, market intelligence covering the rapidly growing hospital market. Specific services include Hospital Pharmacy Audit, IMS MIDAS Prescribing Insights, IMS Disease Analyzer, Oncology Database, Mediflex Omnibus Service, New Stoma Patient Audit and Primary Research Service.

IMS also provides clients with in-depth, topical market studies. We have completed a number of qualitative and quantitative special reports in the past few years, including: Cambridge Pharma Consulting’s Pharmacoeconomics (2002), Generics (2002), and Pricing & Reimbursement (2000).  Recent IMS special studies include: Cerivastatin (2001) and Vaccines (2000).

For further global IMS insights and product information, visit our site for global headquarters: ims-global.com

	To learn more about how IMS can help your company, contact us. For regional contact information, click here.

email this page     print this page